| Literature DB >> 35095589 |
Liana C L Portugal1,2, Camila Monteiro Fabricio Gama2, Raquel Menezes Gonçalves2, Mauro Vitor Mendlowicz3, Fátima Smith Erthal4, Izabela Mocaiber5, Konstantinos Tsirlis6, Eliane Volchan4, Isabel Antunes David2, Mirtes Garcia Pereira2, Leticia de Oliveira2.
Abstract
Background: Healthcare workers are at high risk for developing mental health problems during the COVID-19 pandemic. There is an urgent need to identify vulnerability and protective factors related to the severity of psychiatric symptoms among healthcare workers to implement targeted prevention and intervention programs to reduce the mental health burden worldwide during COVID-19. Objective: The present study aimed to apply a machine learning approach to predict depression and PTSD symptoms based on psychometric questions that assessed: (1) the level of stress due to being isolated from one's family; (2) professional recognition before and during the pandemic; and (3) altruistic acceptance of risk during the COVID-19 pandemic among healthcare workers.Entities:
Keywords: COVID-19; PTSD; depression; healthcare worker (HCW); machine learning
Year: 2022 PMID: 35095589 PMCID: PMC8790177 DOI: 10.3389/fpsyt.2021.752870
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Sociodemographic and occupational characteristics of the participants.
|
| ||
|---|---|---|
|
| ||
|
| ||
| Female | 320 (73.2%) | |
| Male | 117 (27.8%) | |
|
| 39.5 (10.8) | |
|
| ||
| Technician | 87 (19.9%) | |
| Superior | 350 (80.1%) | |
|
| ||
| Medical doctor | 173 (39.6%) | |
| Nurse | 72 (16.5%) | |
| Nurse technician | 60 (13.7%) | |
| Physiotherapist | 43 (9.8%) | |
| Clinical psychologist | 27 (6.2%) | |
| Pharmacist | 19 (4.4%) | |
| Other | 43 (9.8%) | |
|
| ||
| Southeast | 321 (73.5%) | |
| South | 34 (7.8%) | |
| North | 18 (4.1%) | |
| Northeast | 57 (13.0%) | |
| Midwest | 7 (1.6%) | |
|
| ||
| Public | 228 (52.2%) | |
| Private | 86 (19.7%) | |
| Both | 123 (28.1%) | |
|
| ||
| No | 309 (70.7) | |
| Yes | 128 (29.3) | |
|
| ||
| Learning about the death of a close relative or coworker | 94 (21.5%) | |
| Possibly transmitting the COVID-19 virus to another person | 90 (20.6%) | |
| Experiencing the imminent risk of death of a close relative or coworker | 72 (16.5%) | |
| Personally witnessing the death of a patient | 67 (15.3%) | |
| Being infected with COVID-19 | 48 (11.0%) | |
| Being exposed to infected patients at high risk for death | 47 (10.8%) | |
| Personally witnessing the death of a close relative or coworker | 19 (4.3%) | |
The means and standard deviations for the psychometric questions and the scales in the considered sample.
|
|
|
|
|---|---|---|
|
| ||
| Professional recognition (before the pandemic) | 4.4 (1.9) | |
| Professional recognition (during the pandemic) | 7.2 (2.0) | |
| Altruistic acceptance of risk | 7.1 (2.6) | |
|
| ||
| Stress due to social isolation | 7.6 (2.3) | |
|
| ||
| Model1 (PTSD, PCL-5) | 28.6 (17.7) | |
| Model2 (Depression, PHQ-9) | 10.7 (6.8) | |
Figure 1Regression models: (a) The training data for the ε-SVM regression model consists of examples that pair the psychometric factors (stress due to social isolation, altruistic acceptance of risk and professional recognition before and during the pandemic) of each subject and the corresponding clinical score (PCL-5 or PHQ-9). (b) During the training, the ε-SVM model learns the contribution of each psychometric question for the predictive function. (c) During the testing phase, given the psychometric questions of a test subject, the ε-SVM model predicts its corresponding clinical score. (d) The model performance is evaluated using three metrics that measure the agreement between the predicted and actual clinical scores: Pearson's correlation coefficient (r), coefficient of determination (r2) and normalized mean squared error (NMSE).
Measurements of agreement between the actual and decoded scores based on scores of professional recognition, altruistic acceptance of risk and stress level due to social isolation.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| PTSD | “Two-fold” | 0.35 (0.001) | 0.12 (0.001) | 0.96 (0.001) |
| “Five-fold” | 0.34 (0.001) | 0.12 (0.001) | 0.90 (0.001) | |
| Depression | “Two-fold” | 0.36 (0.001) | 0.13 (0.001) | 0.90 (0.001) |
| “Five-fold” | 0.38 (0.001) | 0.15 (0.001) | 0.86 (0.001) | |
For reference: corrected p-value = 0.0125.
Figure 2Scatter plots of actual vs. predicted values applying a two-fold cross-validation scheme for the PTSD symptoms model and for the depression model. (A) Scatter plot between the actual and predicted PCL-5 scores (PTSD symptoms model). (B) Scatter plot between the actual and predicted PHQ-9 scores (depression model).
Figure 3(A) Plot showing the values of the weights for each scale for the prediction of PTSD symptoms. (B) Plot showing the values of the weights for each scale for the prediction of depression symptoms.